Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 5310
Gene Symbol: PKD1
PKD1
0.100 GeneticVariation disease BEFREE The mean (SE) age of onset of ESRD is 56.3 (1.8) years for persons with the PKD1 form of ADPKD, and 68.7 (1.7) years for affected members of families in which ADPKD is not co-inherited with PKD1 markers (P = 0.01). 1605247 1992
Entrez Id: 3458
Gene Symbol: IFNG
IFNG
0.330 AlteredExpression disease BEFREE Regulation of interleukin-2 and interferon-gamma gene expression in renal failure. 1942774 1991
Entrez Id: 3558
Gene Symbol: IL2
IL2
0.010 AlteredExpression disease BEFREE Regulation of interleukin-2 and interferon-gamma gene expression in renal failure. 1942774 1991
Entrez Id: 353
Gene Symbol: APRT
APRT
0.070 GeneticVariation disease BEFREE Homozygous deficiency of a purine salvage enzyme, adenine phosphoribosyltransferase (APRT), causes urolithiasis and renal failure. 2227934 1990
Entrez Id: 353
Gene Symbol: APRT
APRT
0.070 Biomarker disease BEFREE Adenine phosphoribosyltransferase (APRT) deficiency causing 2,8-dihydroxyadenine urolithiasis and renal failure is present at a high frequency among the Japanese but not other ethnic groups. 2227951 1990
Entrez Id: 3458
Gene Symbol: IFNG
IFNG
0.330 Biomarker disease CTD_human Hyponatremia and other toxic effects during a phase I trial of recombinant human gamma interferon and vinblastine. 3091246 1986
Entrez Id: 5741
Gene Symbol: PTH
PTH
0.100 AlteredExpression disease BEFREE The 1,25-dihydroxyvitamin D value was elevated, despite normal serum parathyroid hormone values, high serum phosphate levels, and renal insufficiency. 3332571 1987
Entrez Id: 3029
Gene Symbol: HAGH
HAGH
0.010 Biomarker disease BEFREE Patients with the extended haplotype B8,DR3,SC01,GLO2 had a higher incidence of renal insufficiency than those without it (P less than 0.01). 3458025 1986
Entrez Id: 3440
Gene Symbol: IFNA2
IFNA2
0.300 Biomarker disease CTD_human Interferon alfa-2b/melphalan/prednisone in previously untreated patients with multiple myeloma: a phase I-II trial. 3597002 1987
Entrez Id: 353
Gene Symbol: APRT
APRT
0.070 GeneticVariation disease BEFREE Adenine phosphoribosyltransferase (APRT) deficiency leading to 2,8-dihydroxyadenine (DHA) urolithiasis has been considered a rare cause of urolithiasis and renal insufficiency. 3817810 1987
Entrez Id: 2056
Gene Symbol: EPO
EPO
0.360 Biomarker disease BEFREE The results demonstrate that myoblasts can be transplanted in uremic mice, and that myoblast gene transfer can achieve sufficient and sustained delivery of functionally active EPO to correct anemia associated with renal failure in mice. 7706487 1995
Entrez Id: 1287
Gene Symbol: COL4A5
COL4A5
0.030 GeneticVariation disease BEFREE The X-linked form of Alport disease, caused by mutations in the COL4A5 or the COL4A6 gene, usually leads to terminal renal failure in males, while affected females have a more variable and moderate phenotype. 7706490 1995
Entrez Id: 1288
Gene Symbol: COL4A6
COL4A6
0.010 GeneticVariation disease BEFREE The X-linked form of Alport disease, caused by mutations in the COL4A5 or the COL4A6 gene, usually leads to terminal renal failure in males, while affected females have a more variable and moderate phenotype. 7706490 1995
Entrez Id: 2980
Gene Symbol: GUCA2A
GUCA2A
0.010 Biomarker disease BEFREE Identification of 10-kDa proguanylin as a major guanylin molecule in human intestine and plasma and its increase in renal insufficiency. 7811289 1994
Entrez Id: 5972
Gene Symbol: REN
REN
0.100 Biomarker disease BEFREE In autosomal dominant polycystic kidney disease 1) the genetic localization of the defective gene that causes type 1 disease has been narrowed to 500 to 750 kb on chromosome 16; 2) cystogenesis has been associated with increased cell proliferation, continuing cyst secretion, and a defect in cell polarity; however, the mechanisms by which the genetic defects in autosomal dominant polycystic kidney disease translate into cyst formation are unknown; 3) activation of the renin system has been reported as an important potential cause of hypertension; and 4) factors that influence the progression to renal failure have been identified. 7922177 1993
Entrez Id: 1906
Gene Symbol: EDN1
EDN1
0.500 Biomarker disease CTD_human Elevated levels of the vasocontrictor peptide endothelin-1 have been demonstrated in various pathological conditions that are characterized by sodium retention and/or renal vasoconstriction, such as heart failure, hepatorenal syndrome, renal failure and during administration of cyclosporin and radiocontrast. 7967349 1994
Entrez Id: 1591
Gene Symbol: CYP24A1
CYP24A1
0.300 Biomarker disease CTD_human Effect of vitamin D metabolites on calcitriol degradative enzymes in renal failure. 8164439 1994
Entrez Id: 1287
Gene Symbol: COL4A5
COL4A5
0.030 GeneticVariation disease BEFREE It is not clear why COL4A5 mutations result in glomerulosclerosis and renal failure, or whether this process may be slowed through dietary or pharmacologic intervention. 8238007 1993
Entrez Id: 3458
Gene Symbol: IFNG
IFNG
0.330 Biomarker disease CTD_human Protracted high-dose interferon gamma therapy for chronic experimental nephropathy. 8289579 1994
Entrez Id: 2314
Gene Symbol: FLII
FLII
0.010 Biomarker disease BEFREE These Fli-1 transgenic mice developed a high incidence of a progressive immunological renal disease and ultimately died of renal failure caused by tubulointerstitial nephritis and immune-complex glomerulonephritis. 8524263 1995
Entrez Id: 2313
Gene Symbol: FLI1
FLI1
0.010 Biomarker disease BEFREE These Fli-1 transgenic mice developed a high incidence of a progressive immunological renal disease and ultimately died of renal failure caused by tubulointerstitial nephritis and immune-complex glomerulonephritis. 8524263 1995
Entrez Id: 3630
Gene Symbol: INS
INS
0.300 Biomarker disease CTD_human Losartan-induced azotemia in a diabetic recipient of a kidney transplant. 8606734 1996
Entrez Id: 353
Gene Symbol: APRT
APRT
0.070 Biomarker disease BEFREE Adenine phosphoribosyltransferase (APRT) deficiency in humans is an autosomal recessive syndrome characterized by the urinary excretion of adenine and the highly insoluble compound 2,8-dihydroxyadenine (DHA) that can produce kidney stones or renal failure. 8643571 1996
Entrez Id: 1565
Gene Symbol: CYP2D6
CYP2D6
0.010 AlteredExpression disease BEFREE Assessment of individual CYP2D6 activity in extensive metabolizers with renal failure: comparison of sparteine and dextromethorphan. 8646830 1996
Entrez Id: 2153
Gene Symbol: F5
F5
0.020 GeneticVariation disease BEFREE One hundred-seven individuals without renal failure (57 negative for factor V Leiden, 50 heterozygous subjects) served as controls. 8671856 1996